Baylor Health Care System
 
2 4 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lung cancer - non-small cell

Alternative Names

Cancer - lung - non-small cell; Non-small cell lung cancer; NSCLC

Symptoms

Early lung cancer may not cause any symptoms. Symptoms you should watch for include:

Other symptoms that may be due to NSCLC:

Note: These symptoms can be due to other, less serious conditions. It is important to talk to your health care provider.

Exams and Tests

The health care provider will perform a physical exam and ask questions about your medical history. You will be asked if you smoke, and if so, how long you have smoked.

When listening to the chest with a stethoscope, the health care provider can sometimes hear fluid around the lungs, which could (but doesn't always) suggest cancer.

Tests that may be performed include:

In some cases, the health care provider may need to remove a piece of tissue from your lungs for examination under a microscope. This is called a biopsy. There are several ways to do this:

If the biopsy reveals you do have lung cancer, more imaging tests will be done to determine the stage of the cancer. Stage means how big the tumor is and how far it's spread. Non-small cell lung cancer is divided into five stages:

  • Stage 0 - the cancer has not spread beyond the inner lining of the lung
  • Stage I - the cancer is small and hasn't spread to the lymph nodes
  • Stage II - the cancer has spread to some lymph nodes near the original tumor
  • Stage III - the cancer has spread to nearby tissue or spread to far away lymph nodes
  • Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver

References

Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med. 2006 Jul 10;166(13):1359-67.

American Cancer Society. Cancer Facts and Figures 2006. Atlanta, Ga: American Cancer Society; 2006.

U.S. Preventive Services Task Force. Lung cancer screening. Ann Int Med. 2004;140:738-739.

Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKena WG. Clinical Oncology. 3rd ed. Orlando, Fl: Churchill Livingstone; 2004:1690-1701.

Review Date: 7/31/2006
Reviewed By: Rita Nanda, M.D., Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission. URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2005 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.